Skip to main content
Top
Published in: Tumor Biology 3/2016

01-03-2016 | Original Article

Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells

Authors: Junhao Lin, Yuchen Liu, Yonghao Zhan, Chengle Zhuang, Li Liu, Xing Fu, Wen Xu, Jianfa Li, Mingwei Chen, Zhiming Cai, Weiren Huang

Published in: Tumor Biology | Issue 3/2016

Login to get access

Abstract

Small hairpin RNA (shRNA) can inhibit the malignant phenotypes of tumor cell through ribonucleic acid interference (RNAi). However, it is hardly to be regulated and it may induce few phenotypic changes. Here, we build a type of tetracycline (Tet)-inducible vectors which can achieve regulatable expression of shRNA in a time-dependent manner by using synthetic biology approach. In order to prove the effectiveness of this device, we chose hTERT and Bcl-2 as target genes and test the utility of the device on 5637 and T24 cell lines. The experiments show that the Tet-inducible small hairpin RNA can effectively suppress their target genes and generate anti-cancer effects on both 5637 and T24 cell lines. The device we build not only can inhibit proliferation but also can induce apoptosis and suppress migration of the bladder cancer cell lines 5637 and T24. The Tet-inducible small hairpin RNAs may provide a novel strategy for the treatment of human bladder cancer in the future.
Literature
1.
go back to reference Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64(1):9–29.CrossRef Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64(1):9–29.CrossRef
2.
go back to reference Marta GN, Hanna SA, Gadia R, et al. The role of radiotherapy in urinary bladder cancer: current status. International braz j urol. 2012;38(2):144–56.CrossRefPubMed Marta GN, Hanna SA, Gadia R, et al. The role of radiotherapy in urinary bladder cancer: current status. International braz j urol. 2012;38(2):144–56.CrossRefPubMed
3.
go back to reference Racioppi M, D’Agostino D, Totaro A, et al. Value of current chemotherapy and surgery in advanced and metastatic bladder cancer. Urologia internationalis. 2011;88(3):249–58.CrossRef Racioppi M, D’Agostino D, Totaro A, et al. Value of current chemotherapy and surgery in advanced and metastatic bladder cancer. Urologia internationalis. 2011;88(3):249–58.CrossRef
4.
go back to reference Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296(5567):550–3.CrossRefPubMed Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296(5567):550–3.CrossRefPubMed
5.
go back to reference Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proceedings of the National Academy of Sciences. 2002;99(9):6047–52.CrossRef Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proceedings of the National Academy of Sciences. 2002;99(9):6047–52.CrossRef
6.
go back to reference Chang HS, Lin CH, Chen YC, et al. Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown. The American journal of pathology. 2004;165(5):1535–41.CrossRefPubMedPubMedCentral Chang HS, Lin CH, Chen YC, et al. Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown. The American journal of pathology. 2004;165(5):1535–41.CrossRefPubMedPubMedCentral
7.
go back to reference Seibler J, Kleinridders A, Küter-Luks B, et al. Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic acids research. 2007;35(7):e54.CrossRefPubMedPubMedCentral Seibler J, Kleinridders A, Küter-Luks B, et al. Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic acids research. 2007;35(7):e54.CrossRefPubMedPubMedCentral
8.
go back to reference Kappel S, Matthess Y, Kaufmann M, et al. Silencing of mammalian genes by tetracycline-inducible shRNA expression. Nature protocols. 2007;2(12):3257–69.CrossRefPubMed Kappel S, Matthess Y, Kaufmann M, et al. Silencing of mammalian genes by tetracycline-inducible shRNA expression. Nature protocols. 2007;2(12):3257–69.CrossRefPubMed
9.
go back to reference Melissourgos N, Kastrinakis NG, Davilas I, et al. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker. Urology. 2003;62(2):362–7.CrossRefPubMed Melissourgos N, Kastrinakis NG, Davilas I, et al. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker. Urology. 2003;62(2):362–7.CrossRefPubMed
10.
go back to reference Stavropoulos NE, Filiadis I, Ioachim E, et al. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer. Anticancer research. 2001;22(6B):3759–64. Stavropoulos NE, Filiadis I, Ioachim E, et al. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer. Anticancer research. 2001;22(6B):3759–64.
11.
go back to reference Hörner M, Reischmann N, Weber W. Synthetic biology: programming cells for biomedical applications. Perspectives in biology and medicine. 2012;55(4):490–502.CrossRefPubMed Hörner M, Reischmann N, Weber W. Synthetic biology: programming cells for biomedical applications. Perspectives in biology and medicine. 2012;55(4):490–502.CrossRefPubMed
12.
go back to reference Betten AW, Roelofsen A, Broerse JEW. Interactive learning and action: realizing the promise of synthetic biology for global health. Systems and synthetic biology. 2013;7(3):127–38.CrossRefPubMedPubMedCentral Betten AW, Roelofsen A, Broerse JEW. Interactive learning and action: realizing the promise of synthetic biology for global health. Systems and synthetic biology. 2013;7(3):127–38.CrossRefPubMedPubMedCentral
13.
go back to reference Jain KK. Synthetic biology and personalized medicine. Medical Principles and Practice. 2013;22(3):209–19.CrossRefPubMed Jain KK. Synthetic biology and personalized medicine. Medical Principles and Practice. 2013;22(3):209–19.CrossRefPubMed
14.
go back to reference Ruder WC, Lu T, Collins JJ. Synthetic biology moving into the clinic. Science. 2011;333(6047):1248–52.CrossRefPubMed Ruder WC, Lu T, Collins JJ. Synthetic biology moving into the clinic. Science. 2011;333(6047):1248–52.CrossRefPubMed
15.
go back to reference Folcher M, Fussenegger M. Synthetic biology advancing clinical applications. Current opinion in chemical biology. 2012;16(3):345–54.CrossRefPubMed Folcher M, Fussenegger M. Synthetic biology advancing clinical applications. Current opinion in chemical biology. 2012;16(3):345–54.CrossRefPubMed
17.
go back to reference Chappell J, Watters KE, Takahashi MK, et al. A renaissance in RNA synthetic biology: new mechanisms, applications and tools for the future. Current opinion in chemical biology. 2015;28:47–56.CrossRefPubMed Chappell J, Watters KE, Takahashi MK, et al. A renaissance in RNA synthetic biology: new mechanisms, applications and tools for the future. Current opinion in chemical biology. 2015;28:47–56.CrossRefPubMed
18.
go back to reference Fedorenko V, Genilloud O, Horbal L, et al. Antibacterial discovery and development: from gene to product and back. BioMed Research International. 2015;2015:591349.CrossRefPubMedPubMedCentral Fedorenko V, Genilloud O, Horbal L, et al. Antibacterial discovery and development: from gene to product and back. BioMed Research International. 2015;2015:591349.CrossRefPubMedPubMedCentral
19.
go back to reference Liu X, Tang Q, Chen H, et al. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity. International journal of biological sciences. 2013;9(6):564.CrossRefPubMedPubMedCentral Liu X, Tang Q, Chen H, et al. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity. International journal of biological sciences. 2013;9(6):564.CrossRefPubMedPubMedCentral
20.
go back to reference Liu Y, Zeng Y, Liu L, et al. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nature communications. 2014;5:5393.CrossRefPubMed Liu Y, Zeng Y, Liu L, et al. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nature communications. 2014;5:5393.CrossRefPubMed
21.
go back to reference Knudson AG. Hereditary cancer, oncogenes, and antioncogenes. Cancer Research. 1985;45(4):1437–43.PubMed Knudson AG. Hereditary cancer, oncogenes, and antioncogenes. Cancer Research. 1985;45(4):1437–43.PubMed
Metadata
Title
Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells
Authors
Junhao Lin
Yuchen Liu
Yonghao Zhan
Chengle Zhuang
Li Liu
Xing Fu
Wen Xu
Jianfa Li
Mingwei Chen
Zhiming Cai
Weiren Huang
Publication date
01-03-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 3/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4122-7

Other articles of this Issue 3/2016

Tumor Biology 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine